| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Cyclerion Therapeutics Inc (NASDAQ: CYCN)
CYCN Technical Analysis
5
| As on 21st Nov 2024 CYCN STOCK Price closed @ 1.42 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 3.33 & Strong Sell for SHORT-TERM with Stoploss of 3.89 we also expect STOCK to react on Following IMPORTANT LEVELS. |
CYCNSTOCK Price
| Open | 1.98 | Change | Price | % |
| High | 2.01 | 1 Day | -0.67 | -32.06 |
| Low | 1.42 | 1 Week | -1.15 | -44.75 |
| Close | 1.42 | 1 Month | -1.09 | -43.43 |
| Volume | 688707 | 1 Year | -2.93 | -67.36 |
| 52 Week High 4.62 | 52 Week Low 1.76 | ||||
NASDAQ USA Most Active Stocks
| AMRS | 0.14 | 100.00% |
| NVDA | 146.67 | 0.53% |
| AKTS | 0.10 | 11.11% |
| WORX | 2.12 | 116.33% |
| QUBT | 4.76 | 29.35% |
| LMDX | 0.02 | 0.00% |
| SMCI | 29.70 | 5.06% |
| MSTR | 397.28 | -16.16% |
| MARA | 23.81 | 22.17% |
| CRNC | 5.83 | 106.74% |
NASDAQ USA Top Gainers Stocks
NASDAQ USA Top Losers Stocks
| CYCN Daily Charts |
CYCN Intraday Charts |
Whats New @ Bazaartrend |
CYCN Free Analysis |
|
|
CYCN Important Levels Intraday
| RESISTANCE | 2.56 |
| RESISTANCE | 2.19 |
| RESISTANCE | 1.97 |
| RESISTANCE | 1.74 |
| SUPPORT | 1.10 |
| SUPPORT | 0.87 |
| SUPPORT | 0.65 |
| SUPPORT | 0.28 |
CYCN Forecast November 2024
| 4th UP Forecast | 4.83 |
| 3rd UP Forecast | 3.74 |
| 2nd UP Forecast | 3.06 |
| 1st UP Forecast | 2.38 |
| 1st DOWN Forecast | 0.46 |
| 2nd DOWN Forecast | -0.22 |
| 3rd DOWN Forecast | -0.9 |
| 4th DOWN Forecast | -1.99 |
CYCN Weekly Forecast
| 4th UP Forecast | 2.52 |
| 3rd UP Forecast | 2.17 |
| 2nd UP Forecast | 1.95 |
| 1st UP Forecast | 1.73 |
| 1st DOWN Forecast | 1.11 |
| 2nd DOWN Forecast | 0.89 |
| 3rd DOWN Forecast | 0.67 |
| 4th DOWN Forecast | 0.32 |
CYCN Forecast2024
| 4th UP Forecast | 8.8 |
| 3rd UP Forecast | 6.43 |
| 2nd UP Forecast | 4.97 |
| 1st UP Forecast | 3.51 |
| 1st DOWN Forecast | -0.67 |
| 2nd DOWN Forecast | -2.13 |
| 3rd DOWN Forecast | -3.59 |
| 4th DOWN Forecast | -5.96 |
Cyclerion Therapeutics Inc ( NASDAQ USA Symbol : CYCN )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
CYCN Business Profile
Cyclerion Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovering, development, and commercialization of medicines for serious central nervous system (CNS) diseases. Its product candidates include CY6463, a CNS-penetrant, soluble guanylate cyclase (sGC) stimulator that is in Phase II trials for the treatment of mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes (MELAS) and Alzheimer's disease with vascular pathology (ADv); Olinciguat, an orally administered vascular soluble guanylate cyclase stimulator that is in Phase II studies for the treatment of sickle cell disease (SCD); Praliciguat, an orally administered systemic sGC stimulator that is in Phase II trials for the treatment of diabetic nephropathy and heart failure with preserved ejection fraction. The company was incorporated in 2018 and is headquartered in Cambridge, Massachusetts. Address: 301 Binney Street, Cambridge, MA, United States, 02142
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service